Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia

BACKGROUND: With the emergence of tyrosine kinase inhibitors and the incorporation of stringent measurable residual disease (MRD) monitoring, risk stratification for BCR-ABL1-positive acute lymphoblastic leukemia (ALL) patients has changed significantly. However, whether this monitoring can replace...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Siew Lian, Asnawi, Asral Wirda Ahmad, Leong, Tze Shin, Tan, Jenq Tzong, Law, Kian Boon, Hon, Siong Leng, Fann, Rui Jeat, Tan, Sen Mui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478615/
https://www.ncbi.nlm.nih.gov/pubmed/34462403
http://dx.doi.org/10.5045/br.2021.2021045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478615/
https://www.ncbi.nlm.nih.gov/pubmed/34462403
http://dx.doi.org/10.5045/br.2021.2021045

Ejemplares similares